EFM
E Fund Management’s Beam Therapeutics BEAM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $233K | Buy |
13,675
+2,472
| +22% | +$42K | 0.01% | 344 |
|
2025
Q1 | $219K | Buy |
+11,203
| New | +$219K | 0.01% | 350 |
|
2024
Q4 | – | Sell |
-12,020
| Closed | -$294K | – | 400 |
|
2024
Q3 | $294K | Buy |
12,020
+1,983
| +20% | +$48.6K | 0.02% | 264 |
|
2024
Q2 | $235K | Sell |
10,037
-1,510
| -13% | -$35.4K | 0.01% | 265 |
|
2024
Q1 | $382K | Sell |
11,547
-6,627
| -36% | -$219K | 0.02% | 232 |
|
2023
Q4 | $495K | Buy |
18,174
+704
| +4% | +$19.2K | 0.03% | 171 |
|
2023
Q3 | $420K | Buy |
17,470
+3,603
| +26% | +$86.6K | 0.03% | 159 |
|
2023
Q2 | $443K | Buy |
13,867
+1,851
| +15% | +$59.1K | 0.04% | 138 |
|
2023
Q1 | $368K | Buy |
12,016
+1,981
| +20% | +$60.7K | 0.03% | 196 |
|
2022
Q4 | $392K | Buy |
10,035
+1,752
| +21% | +$68.4K | 0.03% | 185 |
|
2022
Q3 | $395K | Sell |
8,283
-4,954
| -37% | -$236K | 0.04% | 185 |
|
2022
Q2 | $512K | Buy |
13,237
+8,833
| +201% | +$342K | 0.05% | 137 |
|
2022
Q1 | $252K | Buy |
+4,404
| New | +$252K | 0.01% | 255 |
|